insights_auto
Kwa nini NOTA imeongezeka kwa 5.69%?
Fahamu zaidichevron_right
NOTA:FRA
Novartis AG
€ 130.00
arrow_upward
+5.69%(+7.00) Siku 1
7 Okt, 22:00:00 GMT +2 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya NOTA...
Fungua
€ 122.00
Juu
€ 130.00
Chini
€ 122.00
Mtaji wa soko
291.87B
Wastani wa kiasi cha mauzo
27.00
Kiasi cha mauzo ya hisa
12.00
Juu kwa wiki 52
€ 145.00
Chini kwa wiki 52
€ 102.50
Idadi ya wafanyakazi
elfu 75
Fungua
€ 122.00
Juu
€ 130.00
Chini
€ 122.00
Mtaji wa soko
291.87B
Wastani wa kiasi cha mauzo
27.00
Kiasi cha mauzo ya hisa
12.00
Juu kwa wiki 52
€ 145.00
Chini kwa wiki 52
€ 102.50
Idadi ya wafanyakazi
elfu 75
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
AD HOC NEWS
·
saa 2 zilizopita
SMI closes 0.14 percent higher as pharma shares offset yield pressure
AD HOC NEWS
·
saa 6 zilizopita
Novartis to present 46 MS abstracts; stock after-hours at EUR 128.88, plus 3.43 percent
AD HOC NEWS
·
saa 11 zilizopita
Novartis stock draws a Hold consensus before Q3 results
Yahoo Finance
·
saa 12 zilizopita
AI companies run virtual drug trials, aim to improve success of human studies
Wasifu
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Kuhusu Novartis AG
Afisa Mkuu Mtendaji (CEO)Vasant Narasimhan
Wafanyakazielfu 75.3
Lilianzishwa7 Mac 1996
Makao makuuBasel, Mji wa Basel, Uswisi
Sekta-
Tovutinovartis.com